Debiopharm has deployed the Genialis™ Expressions software platform within its cloud infrastructure to support its drug development with biomarker discovery and multiomics data analytics. The agreement extends our companies’ multi-year collaboration and provides Debiopharm access to Genialis’ integrated technology stack for raw data processing and AI-driven biomarker modeling.
“Genialis Expressions solves one of our most persistent challenges: relying on different vendors and workflows to process our omics data, which makes it extremely difficult to compare datasets across studies,” said Frederico Braga, Head of Digital and IT at Debiopharm. “By establishing a centralized, in-house platform, Genialis Expressions gives us a single standardized pipeline, ensuring consistency across all omics datasets and enabling true cross-study comparability.”